Kiniksa Pharmaceuticals International Plc (KNSA)
95.76
+0.74
(+0.78%)
USD |
NASDAQ |
Nov 11, 16:00
95.83
+0.07
(+0.07%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Gross Profit Margin (Quarterly) : 53.22% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 53.22% |
| June 30, 2026 | 54.10% |
| March 31, 2026 | 54.95% |
| December 31, 2025 | 54.93% |
| September 30, 2025 | 53.78% |
| June 30, 2025 | 54.70% |
| March 31, 2025 | 55.23% |
| December 31, 2024 | 46.00% |
| September 30, 2024 | 55.89% |
| June 30, 2024 | 60.92% |
| March 31, 2024 | 60.51% |
| Date | Value |
|---|---|
| December 31, 2023 | 67.91% |
| September 30, 2023 | 59.14% |
| June 30, 2023 | 68.18% |
| March 31, 2023 | 65.97% |
| December 31, 2022 | 75.25% |
| September 30, 2022 | 87.38% |
| June 30, 2022 | 63.68% |
| March 31, 2022 | 57.85% |
| December 31, 2021 | 68.98% |
| September 30, 2021 | 68.23% |
| June 30, 2021 | 54.80% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.83% |
| Return on Assets | 13.10% |
| Return on Invested Capital | 17.57% |
| Profit Margin (Quarterly) | 16.56% |
| Operating Margin (Quarterly) | 18.97% |
| Return on Net Operating Assets | 87.82% |